Amgen’s $400 million eczema drug candidate has recorded two more phase 3 victories. The data drops provide more evidence that the Kyowa Kirin-partnered rocatinlimab improves outcomes in atopic ...
Praxis Precision Medicines has been blindsided by a recommendation to stop a phase 3 essential tremor trial. Two months after CEO Marcio Souza said the chances of the trial being futile were ...
--(BUSINESS WIRE)--Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) today announced positive topline results for the Phase 3 VERIFY study, in which ...
CHICAGO (WGN) — As the third and final phase of Kennedy construction work ... IDOT originally projected the cost of the entire three year Kennedy Expressway construction project would be $ ...
BioXcel Therapeutics (BTAI) announced that the U.S. Food and Drug Administration has concluded that the inspection of a single site in its TRANQUILITY II Phase 3 trial is closed under 21 C.F.R.20. ...
and NEW YORK, March 11, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN) and Pfizer Inc. (NYSE: PFE) today announced positive topline results from the Phase 3 VERITAC-2 clinical trial ...
Amgen still needs to show that the reduction in Lp(a) is accompanied by lower rates of cardiovascular outcomes, and will endeavour to show that in its phase 3 programme which will start to enrol a ...
As December 2022 closed out, Pfizer announced positive top-line results from its phase 3 BENEGENE-2 study evaluating fidanacogene elaparvovec (SPK-9001), its investigational gene therapy for ...
Blackwing Lair is the headline PVE activity in Phase 3 but before players can take on this level 60 raid and the 8 bosses within, they’ll need to complete a short attunement questline that takes them ...
The phase 3 VERIFY study (NCT05210790) demonstrated that rusfertide (PTG-300), a hepcidin mimetic, significantly outperformed placebo in achieving clinical response among phlebotomy-dependent patients ...
OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) today announced positive topline results for the Phase 3 ...
9 Nintendo Switch 2 Games It NEEDS to Have - Super Mario Odyssey 2 & More! Watch on YouTube The second phase of Nintendo's game launch plan is then reportedly set for around October-November ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results